World Biosimilars Market Drivers and Challenges Report 2020Pharmaceutical ResearchUpdated on Sep 13, 2016 View more like this | Visit MONTCLAIR, NJ | Contact anushka rane |
Global Biosimilars Market 2016-2020 is the latest addition to Sandlerresearch.org industry research reports collection.
Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product. They have many similarities, but are not identical to, the reference biopharmaceutical product.
The analysts forecast Global Biosimilars Market to grow at a CAGR of 55.52% during the period 2016-2020.
Covered in this Report
This report covers the present scenario and the growth prospects of the global Biosimilars Market for 2016-2020.
Inquire for more information @ http://www.sandlerresearch.org/inquire-before-buying?rname=58557
Key regions
Americas
APAC
EMEA
Key vendors
Biocon
Celltrion
Dr. Reddy’s Laboratories
Hospira
Sandoz
STADA
Teva Pharmaceuticals
Other prominent vendors
3SBio
Accord Healthcare
AET Biotech
Allergan
Alvartis Pharma
Amega Biotech
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo Pharma
Baxter
Bharat Serums
Bio Sidus
Biogen
Bionovis
Bioton
BioXpress Therapeutics
Boehringer Ingelheim
Boston Oncology
Cipla
Coherus Biosciences
Daiichi Sankyo
Emcure Pharmaceuticals
Gedeon Richter
GeneScience Pharmaceuticals
GSK
Hetero Drugs
iBio
Intas Pharmaceuticals
JCR Pharmaceuticals
LG Lifesciences
Lonza
Merck
Mitsubishi Tanabe Pharma
Momenta Pharmaceuticals
Mylan
Natco Pharma
Novartis
Pfenex
Pfizer
Ranbaxy Laboratories
Roche Holding
Samsung Biologics
Sanofi
Synthon
Wockhardt
Zydus Cadila Healthcare
Purchase a Copy of the Report @ http://www.sandlerresearch.org/purchase?rname=58557
Market driver
Rise in number of patent expiries
For a full, detailed list, view our report
Market challenge
Physicians reluctance to prescribe biosimilars
For a full, detailed list, view our report
Market trend
Emergence of biosimilars
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount @ http://www.sandlerresearch.org/discount?rname=58557
Contact [email protected] / Call +1 888 391 5441 for further information on “Global Biosimilars Market 2016-2020”report OR for any other market research and intelligence needs you may have for your business.
Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product. They have many similarities, but are not identical to, the reference biopharmaceutical product.
The analysts forecast Global Biosimilars Market to grow at a CAGR of 55.52% during the period 2016-2020.
Covered in this Report
This report covers the present scenario and the growth prospects of the global Biosimilars Market for 2016-2020.
Inquire for more information @ http://www.sandlerresearch.org/inquire-before-buying?rname=58557
Key regions
Americas
APAC
EMEA
Key vendors
Biocon
Celltrion
Dr. Reddy’s Laboratories
Hospira
Sandoz
STADA
Teva Pharmaceuticals
Other prominent vendors
3SBio
Accord Healthcare
AET Biotech
Allergan
Alvartis Pharma
Amega Biotech
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo Pharma
Baxter
Bharat Serums
Bio Sidus
Biogen
Bionovis
Bioton
BioXpress Therapeutics
Boehringer Ingelheim
Boston Oncology
Cipla
Coherus Biosciences
Daiichi Sankyo
Emcure Pharmaceuticals
Gedeon Richter
GeneScience Pharmaceuticals
GSK
Hetero Drugs
iBio
Intas Pharmaceuticals
JCR Pharmaceuticals
LG Lifesciences
Lonza
Merck
Mitsubishi Tanabe Pharma
Momenta Pharmaceuticals
Mylan
Natco Pharma
Novartis
Pfenex
Pfizer
Ranbaxy Laboratories
Roche Holding
Samsung Biologics
Sanofi
Synthon
Wockhardt
Zydus Cadila Healthcare
Purchase a Copy of the Report @ http://www.sandlerresearch.org/purchase?rname=58557
Market driver
Rise in number of patent expiries
For a full, detailed list, view our report
Market challenge
Physicians reluctance to prescribe biosimilars
For a full, detailed list, view our report
Market trend
Emergence of biosimilars
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount @ http://www.sandlerresearch.org/discount?rname=58557
Contact [email protected] / Call +1 888 391 5441 for further information on “Global Biosimilars Market 2016-2020”report OR for any other market research and intelligence needs you may have for your business.
